Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Aoki S et al. - The results indicate that vimentin-positive MC originating from the heart, spleen, lung, liver and kidney can support epidermal regeneration without the involvement of mesenchymal stem cell and myofibroblast phenotypes of MC.

Related Articles

Neuroprotective effect of combined hypoxia-induced VEGF and bone marrow-derived mesenchymal stem cell treatment
Child's Nervous System, 11/20/09    Relevance Score: 82%

Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation
Nephrology Dialysis Transplantation, 11/05/09    Relevance Score: 81%

Mesenchymal Stem Cell Homing Capacity
Transplantation, 10/29/09    Relevance Score: 81%

Mesenchymal Stem Cells for Bone Repair and Metabolic Bone Diseases
Mayo Clinic Proceedings, 10/09/09    Relevance Score: 81%

Therapeutic Potential of Adult Bone Marrow-Derived Mesenchymal Stem Cells in Prostate Cancer Bone Metastasis
Clinical Cancer Research, 11/23/09    Relevance Score: 80%

Today in Dermatologic Oncology...keeping you current

Phase II trial of temozolomide and sorafenib in advanced melanoma patients with or without brain metastases
Clinical Cancer Research, 12/10/09

Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity
Proceedings of the National Academy of Sciences of the United States of America, 12/10/09

Dynamic Gene Expression Analysis Links Melanocyte Growth Arrest with Nevogenesis
Cancer Research, 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address